We use cookies to help you navigate efficiently and perform analytical or advertising functions. By clicking “Accept All Cookies” or continuing to use our website, you consent to the placement of all cookies. You can adjust your cookie preferences by clicking “Cookie Settings”.

For more information, please refer to our Privacy and Cookie Policy.
Healthcare Asia Pacific
Home > Events & Announcements > Coronavirus (COVID-19) Corporate Statement

Coronavirus (COVID-19) Corporate Statement

By Omron Healthcare, 02 Apr 2020

OMRON Healthcare is responding to the ongoing global Coronavirus (COVID-19) outbreak in accordance with our mission to improve lives and contribute to a better society.

We strive to ensure continued supply and distribution of our healthcare devices and to protect the safety and wellbeing of all our employees around the world. After initial reports of the Coronavirus outbreak the OMRON Healthcare Group has constituted a global task force to address, monitor and mitigate the impact. 

Since the Coronavirus outbreak reached the pandemic status, the entire global supply chain has been impacted, leading the disruption in logistic capabilities and production capacity. We monitor the situation carefully and implement measures to safeguard the supply of our products and maintain quality standards. 

We are seeing a shift in demand for our consumer product portfolio in the most affected regions with an increase for our respiratory and thermometer device categories. To fulfil the needs of our customers and health care providers, we are working vigilantly with our partners across the world to ensure product availability.  

To help protect the health and wellbeing of all our employees, and contribute to limiting the spread of the virus, we have promptly implemented temporary measures to help reduce the risk of infection. Guidance for working-from-home, as well as restricting business travel, off-site meetings and external visitors were implemented in the early stages of the outbreak. Our guidance is aligned with local government authorities.

Leveraging our technological expertise in respiratory disease treatment, we are mobilizing our R&D teams to rapidly deliver solutions and provide guidance to health care providers. Answering to the needs created by Coronavirus pandemic we are accelerating the development of Remote Patient Monitoring programs for hypertension aiming to relief the strain on healthcare providers globally.

As a company tied closely to the health and wellness of those we serve, our thoughts are with our consumers and our dedication and resolve continues toward our Going for Zero mission to save lives.

Sincerely, 
Isao Ogino
President and CEO
OMRON Healthcare Co.,Ltd. 

For latest information, please visit global Omron Healthcare website.
Click here for info about Cardiovascular Health and COVID-19. 



 
Return to Events Page